Houston Center for Quality of Care and Utilization Studies
Houston, Texas, 77030, United States
NCT Number: NCT00308724
The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of health, decreased life satisfaction, and increased loneliness. Because many older adults with anxiety seek assistance in a medical setting, treatment has been primarily pharmacological. There is, however, limited evidence of the effectiveness of psychotropic medications. Given the potential difficulties in prescribing psychotropic medications in later life (e.g., increased adverse effects, potential drug interactions), psychosocial treatments may be important alternative or adjuncts.
The treatment phase of this study lasts 10 weeks, during which patients will be randomly assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12 months after treatment completion, during which time patients will complete telephone assessments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8 to 10 in person CBT sessions up to 60 minutes in duration within a 12 week time period
Other names: CBT
Biweekly telephone calls to monitor symptom severity, an enhanced Usual Care condition
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Time frame: Baseline and 3, 6, 9, 12 and 15 months
Baylor College of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05970510
Anxiety Disorders, Generalized Anxiety Disorder
Beijing, China
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT03585010
Anxiety Disorder of Childhood, Anxiety Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06124014
Anxiety Disorders, Generalized Anxiety Disorder
Chapel Hill, North Carolina, United States
View Trial Details